We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$46.4B
1-Year Est. Return
27.74%
This Fund
S&P 500
This Quarter
Est. Return
-1.94%
1 Year Est. Return
+27.74%
3 Year Est. Return
+73.33%
5 Year Est. Return
+93.31%
10 Year Est. Return
+303.34%
AUM
$55.3B
AUM Growth
-$3.5B
(-5.9%)
Cap. Flow
-$1.95B
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
14.44%
Holding
951
New
37
Increased
176
Reduced
438
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qorvo
QRVO
|
+$166M |
| 2 |
Fox Class A
FOXA
|
+$160M |
| 3 |
ExxonMobil
XOM
|
+$95.5M |
| 4 |
Intel
INTC
|
+$80.6M |
| 5 |
Murphy USA
MUSA
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$314M |
| 2 |
HCA Healthcare
HCA
|
+$229M |
| 3 |
VER
VEREIT, Inc.
VER
|
+$154M |
| 4 |
Exelon
EXC
|
+$138M |
| 5 |
Textron
TXT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.12% |
| 2 | Technology | 14.59% |
| 3 | Healthcare | 14.15% |
| 4 | Consumer Discretionary | 12.76% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Norwegian Cruise Line
NCLH
$8.51B
| $3.13M | 0.01% |
117,200
-75,800
| -39% | -$1.93M |
|
|
FONR
602
DELISTED
Fonar
FONR
| $3.13M | 0.01% |
202,455
-8,400
| -4% | -$142K |
|
603
Chubb
CB
$135B
| $3.1M | 0.01% |
17,899
+5,500
| +44% | +$964K |
|
|
RC
604
Ready Capital
RC
$258M
| $3.02M | 0.01% |
209,122
+124,799
| +148% | +$1.89M |
|
605
Chevron
CVX
$392B
| $3M | 0.01% |
29,600
+11,500
| +64% | +$1.15M |
|
|
MOFG
606
DELISTED
MidWestOne Financial Group
MOFG
| $2.93M | 0.01% |
97,088
| – | – |
|
607
Smith & Wesson
SWBI
$651M
| $2.92M | 0.01% |
+140,600
| New | +$3.38M |
|
608
ANI Pharmaceuticals
ANIP
$1.8B
| $2.91M | 0.01% |
88,700
| – | – |
|
609
Collegium Pharmaceutical
COLL
$1.15B
| $2.9M | 0.01% |
+146,900
| New | +$3.18M |
|
610
Alpha and Omega Semiconductor
AOSL
$950M
| $2.89M | 0.01% |
+92,173
| New | +$2.55M |
|
611
CNB Financial Corp
CCNE
$1.04B
| $2.84M | 0.01% |
116,682
| – | – |
|
612
Genworth Financial
GNW
$3.76B
| $2.74M | 0.01% |
731,142
-67,371
| -8% | -$240K |
|
613
Coca-Cola Europacific Partners
CCEP
$48.3B
| $2.73M | ﹤0.01% |
49,400
| – | – |
|
|
TGH
614
DELISTED
Textainer Group Holdings limited
TGH
| $2.68M | ﹤0.01% |
76,800
| – | – |
|
615
Atlantic Union Bankshares
AUB
$6.02B
| $2.61M | ﹤0.01% |
70,947
-3,000
| -4% | -$108K |
|
|
IPG
616
DELISTED
Interpublic Group of Companies
IPG
| $2.59M | ﹤0.01% |
70,600
-19,200
| -21% | -$687K |
|
617
Apple Hospitality REIT
APLE
$3.9B
| $2.57M | ﹤0.01% |
163,579
| – | – |
|
618
Scotiabank
BNS
$107B
| $2.56M | ﹤0.01% |
41,600
| – | – |
|
619
Edison International
EIX
$28.2B
| $2.48M | ﹤0.01% |
44,700
-9,200
| -17% | -$528K |
|
620
Procter & Gamble
PG
$336B
| $2.46M | ﹤0.01% |
17,600
+9,100
| +107% | +$1.29M |
|
621
RLJ Lodging Trust
RLJ
$1.86B
| $2.44M | ﹤0.01% |
164,340
-21,200
| -11% | -$304K |
|
622
Cencora
COR
$60.6B
| $2.42M | ﹤0.01% |
20,227
| – | – |
|
623
Enterprise Financial Services Corp
EFSC
$2.4B
| $2.4M | ﹤0.01% |
53,016
+20,916
| +65% | +$937K |
|
624
NACCO Industries
NC
$357M
| $2.37M | ﹤0.01% |
79,319
| – | – |
|
625
Costamare
CMRE
$1.88B
| $2.33M | ﹤0.01% |
150,600
| – | – |
|
Similar funds
LP
TI
LSV Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, LSV Asset Management held 951 positions worth $55.3B, down 5.9% from $58.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
LSV Asset Management withdrew a net $1.95B in Q3 2021, closing 47 positions and reducing 438 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $314M position sold in full.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, LSV Asset Management opened a new position in Ryder worth $24.7M.
- LSV Asset Management's largest Q3 2021 buy was Ryder: 298,150 shares worth $24.7M.
- LSV Asset Management added most to Qorvo in Q3 2021, an estimated $166M increase.
- LSV Asset Management's biggest Q3 2021 reduction was HCA Healthcare, cutting an estimated $229M.
- LSV Asset Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $314M.
- LSV Asset Management's ten largest holdings make up 14% of its $55.3B portfolio in Q3 2021.
- LSV Asset Management opened 37 new positions and closed 47 in Q3 2021.
- LSV Asset Management's portfolio value fell 5.9% quarter-over-quarter to $55.3B.
Based on LSV Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.